Devil's Claw is a perennial plant native to parts of southern Africa. It belongs to the Pedaliaceae family and is named after the distinctive hooked structures on its fruit. The plant's secondary roots are commonly used to prepare botanical extracts.
Devil's Claw has a history of traditional use and has been studied for its characteristic phytochemical composition. Its root material contains iridoid glycosides, including harpagoside, harpagide, and procumbide. The concentration of these compounds varies with the botanical source, growing conditions, processing methods, and extraction procedure.
Commercial Devil's Claw Extract may be supplied in different grades and standardization levels. Buyers should verify the plant part, extract ratio, harpagoside content, and other relevant parameters using the product-specific technical documentation.
The roots are processed using suitable extraction techniques to obtain botanical materials with different chemical profiles. The final composition depends on the extraction solvent, processing conditions, and concentration method.
Harpagoside is an iridoid glycoside commonly used as a marker compound for Devil's Claw root extracts. Its concentration may be specified in standardized products and assessed using suitable analytical methods.
Harpagide is another iridoid glycoside reported in Devil's Claw. Its presence and concentration depend on the source material and extraction process.
Procumbide and other related iridoid glycosides have been reported in Devil's Claw root material. The specific compounds present in a commercial extract should be confirmed through appropriate analytical testing.
Depending on the extract, additional constituents may be present. The chemical profile can vary between raw root material, powdered root, and concentrated extracts.
The actual composition of a commercial product should be established using the product specification and Certificate of Analysis (CoA). A harpagoside percentage should not be assumed without supporting analytical evidence.
Devil's Claw Extract may be evaluated for selected herbal formulation projects where the ingredient grade and intended use comply with applicable regulations. Formulators should review the extract's composition, quality documentation, safety information, and intended-use requirements.
The plant is relevant to research involving iridoid glycosides, botanical extraction, marker-compound analysis, and the characterization of plant-derived materials.
Certain Devil's Claw extracts may be considered for nutraceutical development, subject to the exact product grade, safety assessment, and applicable regulatory requirements.
Devil's Claw root extracts may be evaluated for botanical identity, harpagoside concentration, extract consistency, and other relevant quality parameters. HPLC or another validated analytical method may be used to quantify specified marker compounds.
These potential applications do not establish clinical effectiveness or guarantee suitability for every formulation. Any health-related claim must be supported by appropriate evidence and comply with applicable regulations.
Quality control is important when selecting Devil's Claw Extract for research or commercial use. Depending on the product grade, specifications may include:
HPLC or another suitable validated analytical method may be used to determine harpagoside content. The method, reference standard, and reporting basis should be documented.
A current batch-specific CoA should be reviewed before publishing numerical assay values or claims about standardization.
Store Devil's Claw Extract according to the instructions provided for the exact product. Use suitable packaging and protect the material from excessive heat, moisture, and other unsuitable environmental conditions.
Follow the product-specific technical documentation and applicable safety handling procedures.
When selecting Devil's Claw Extract, buyers should verify the scientific name, plant part, extraction method, extract ratio, harpagoside concentration, and intended application.
Different extracts may have different chemical profiles and standardization levels. Reviewing the technical data sheet and batch-specific CoA helps determine whether the material meets the intended requirements.
Devil's Claw Extract (Harpagophytum procumbens) is a botanical ingredient recognized for its iridoid glycosides, particularly harpagoside. Its composition and suitability depend on the plant material, extraction process, standardization, analytical testing, and intended use.
For informed ingredient selection, review the product specification, botanical identity, and batch-specific Certificate of Analysis before making purchasing or formulation decisions.
| Parameter | Specification |
|---|---|
| Identification | Harpagophytum procumbens |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Devil's Claw Extract (Harpagophytum procumbens) Manufacturer in India | Mediocon Inc. and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Devil's Claw Extract (Harpagophytum procumbens) Manufacturer in India | Mediocon Inc. is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance